CN1194859A - Medicine for treating colitis - Google Patents
Medicine for treating colitis Download PDFInfo
- Publication number
- CN1194859A CN1194859A CN98111226A CN98111226A CN1194859A CN 1194859 A CN1194859 A CN 1194859A CN 98111226 A CN98111226 A CN 98111226A CN 98111226 A CN98111226 A CN 98111226A CN 1194859 A CN1194859 A CN 1194859A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- medicine
- bletillae
- magnesium sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine for treating colitis is prepared from pomegranate rind, chicken's gizzard-skin, Chuang-Xiong rhizome, bletilla tuber, rhubarb and dried ginger through washing, baking, sterilization, crushing and mixing with fruit acid and magnesium sulfate, and features high total effective rate and cure rate and no toxic by-effect.
Description
The present invention relates to a kind of medicine for the treatment of colitis, specifically is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Colitis is the common frdquently encountered disease of serious harm human health, and clinical symptoms is that the patient often suffers from abdominal pain, suffers from diarrhoea, and accompanies by the dense hemafecia of mucus shape.Tracing it to its cause, mainly is large intestine mucous hyperemia edema, curing ulcer erosion.Because this disease is outbreak repeatedly easily, delay with the passing of time, so patient's liver,spleen,kidney all has in various degree impaired.
The medicine of treatment colitis mainly is the Western medicine norfloxacin at present.Though this medicine also has certain therapeutic effect, curative effect is not fairly obvious, cure rate less than 40%.And also have certain side effect, as diseases such as dizziness, headache, abdominal discomforts, one or two people also may cause the rising of changeing the mould and blood urea nitrogen of ammonia.
The object of the present invention is to provide the medicine of the treatment colitis that a kind of curative effect is obvious, cure rate is high, have no side effect.
Solution of the present invention is based on motherland's medical science pathogenetic understanding of intestinal tract disease and Therapeutic Principle, achieve with reference to modern pharmacological research, from motherland's medical treasure-house, filter out have heat-clearing and toxic substances removing, natural edible-plant medicine that function is descended in dampness removing convergence, granulation promoting antidiarrheal, spleen invigorating warming YANG, blood circulation promoting and blood stasis dispelling, convergence admittedly, process by the tcm theory prescription.
Medicine of the present invention is made (consumption is a weight portion) by following component:
30～50 parts of Pericarpium Granatis, 10～20 parts of Endothelium Corneum Gigeriae Galli, 10～20 parts of fruit acid, 3～10 parts of Rhizoma Chuanxiongs, 10～20 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 3～10 parts of Radix Et Rhizoma Rhei, 5～10 parts of Rhizoma Zingiberiss, 3～10 parts in magnesium sulfate.
The formula optimization weight proportion scope of preparation medicine of the present invention is:
30～45 parts of Pericarpium Granatis, 12～18 parts of Endothelium Corneum Gigeriae Galli, 12～18 parts of fruit acid, 4～8 parts of Rhizoma Chuanxiongs, 12～18 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 4～8 parts of Radix Et Rhizoma Rhei, 6～8 parts of Rhizoma Zingiberiss, 5～8 parts in magnesium sulfate.
The optimum weight proportioning of medicine of the present invention is:
40 parts of Pericarpium Granatis, 10 parts of Endothelium Corneum Gigeriae Galli, 12 parts of fruit acid, 3 parts of Rhizoma Chuanxiongs, 13 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 6.5 parts of Radix Et Rhizoma Rhei, 7.5 parts of Rhizoma Zingiberiss, 7 parts in magnesium sulfate.
Above-mentioned each component is made medicine production method of the present invention is:
Earlier Pericarpium Granati, Endothelium Corneum Gigeriae Galli, Rhizoma Chuanxiong, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Et Rhizoma Rhei, Rhizoma Zingiberis are cleaned the back behind gap dry disinfection under 80 ℃ the temperature, processing powder is broken into 100 order fine powders, mixes with fruit acid, magnesium sulfate again, makes drug powder of the present invention.
Medicine of the present invention has following advantage:
1, effective percentage and cure rate height.Medicine of the present invention through Harbin 15 hospital clinicals such as the 156th hospital use, to the 108 routine colitis patients that accept for medical treatment as test group.In this 108 routine patient: male 48 examples, women 60 examples; 45 years old mean age; 1～5 year person's 58 example of the course of disease, 6～10 years person's 19 examples, 11～20 years person's 19 examples, 21～30 years person's 9 examples, person's 3 examples more than 31 years.Wherein, gastroptosis person 6 examples, the large stretch of intestinal mucosa person of coming off 2 examples.Use medicine of the present invention to take the method that adds external application for oral administration to treat, 10 days is a course of treatment, totally three courses of treatment.Method for oral administration is: 2 grams/time, day clothes three times, ante cibum, boiled water was taken after mixing it with water.Outer coating method is: get medicine 50 grams of the present invention, put into container, with the dried pasty state of tablet vinegar furnishing, add a cover Steam by water bath after 15 minutes, wrap with cloth, apply on SHENQUE acupoint (umbilicus), every night once.And to select sex, age, medical history, colitis patient's 40 examples that the state of an illness is suitable be matched group, and employing Western medicine norfloxacin is treated, and the therapeutic outcome of test group and matched group is listed in the table below:
Medicine of the present invention and Western medicine norfloxacin treatment colitis is synopsis as a result
| Group | Case | The recovery from illness number accounts for % | Good revolution accounts for % | Invalid number accounts for % | Total effective rate |
| Test group | ??108 | ??79，?73.15％ | ?25，23.15％ | ??4，??3.7％ | ???96.3％ |
| Matched group | ???40 | ??15，??37.5％ | ??18，??45％ | ??7，17.5％ | ???82.5％ |
By table as seen, with Drug therapy colitis of the present invention, cure rate and total effective rate are all very high.
2, without any side effects.The patient diseases such as dizziness, headache, abdominal discomfort can not occur, can not cause the rising of changeing the mould and blood urea nitrogen of ammonia.
Embodiment:
Get 4.0 kilograms of Pericarpium Granatis, 1.0 kilograms of Endothelium Corneum Gigeriae Galli, 1.2 kilograms of fruit acid, 0.3 kilogram of Rhizoma Chuanxiong, 1.3 kilograms of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 0.65 kilogram of Radix Et Rhizoma Rhei, 0.75 kilogram of Rhizoma Zingiberis, 0.7 kilogram in magnesium sulfate, earlier Pericarpium Granati, Endothelium Corneum Gigeriae Galli, Rhizoma Chuanxiong, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Et Rhizoma Rhei, Rhizoma Zingiberis being cleaned and being placed on temperature is in 80 ℃ the baking oven, carry out twice of gap drying, sterilization, each 240 minutes, then, processing powder is broken into 100 order fine powders; Mix with fruit acid, magnesium sulfate again, make powder.As required, also can be made into fast agent, or become pill with the capsule fill.
Claims (5)
1, a kind of medicine for the treatment of colitis is characterized in that the medicament of being made by following materials of weight proportions:
30～50 parts of Pericarpium Granatis; 10～20 parts of Endothelium Corneum Gigeriae Galli; 10～20 parts of fruit acid; 3～10 parts of Rhizoma Chuanxiongs; 10～20 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s; 3～10 parts of Radix Et Rhizoma Rhei; 5～10 parts of Rhizoma Zingiberiss; 3～10 parts in magnesium sulfate.
2, according to claims 1 described medicine, it is characterized in that the weight proportion of each raw material is:
30～45 parts of Pericarpium Granatis; 12～18 parts of Endothelium Corneum Gigeriae Galli; 12～18 parts of fruit acid; 4～8 parts of Rhizoma Chuanxiongs; 12～18 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s; 4～8 parts of Radix Et Rhizoma Rhei; Rhizoma Zingiberis 6～8; 5～8 parts in magnesium sulfate.
3, medicine according to claim 1 is characterized in that the weight proportion of each raw material is:
40 parts of Pericarpium Granatis; 10 parts of Endothelium Corneum Gigeriae Galli; 12 parts of fruit acid; 3 parts of Rhizoma Chuanxiongs; 13 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s; 6.5 parts of Radix Et Rhizoma Rhei; 7.5 parts of Rhizoma Zingiberiss; 7 parts in magnesium sulfate.
4,, it is characterized in that said medicament is a said dosage form on any pharmaceutics according to claim 1,2 or 3 described medicines.
5,, it is characterized in that said medicament is powder, piece agent or pill according to the said medicine of claim 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98111226A CN1194859A (en) | 1998-04-03 | 1998-04-03 | Medicine for treating colitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98111226A CN1194859A (en) | 1998-04-03 | 1998-04-03 | Medicine for treating colitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1194859A true CN1194859A (en) | 1998-10-07 |
Family
ID=5221222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98111226A Pending CN1194859A (en) | 1998-04-03 | 1998-04-03 | Medicine for treating colitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1194859A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104288728A (en) * | 2014-10-14 | 2015-01-21 | 杨华岳 | Traditional Chinese medicine for treating diarrhea-predominant pattern irritable bowel syndromes |
-
1998
- 1998-04-03 CN CN98111226A patent/CN1194859A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104288728A (en) * | 2014-10-14 | 2015-01-21 | 杨华岳 | Traditional Chinese medicine for treating diarrhea-predominant pattern irritable bowel syndromes |
| CN104288728B (en) * | 2014-10-14 | 2017-10-03 | 杨华岳 | A kind of Chinese medicine for treating diarrhea-type irritability syndrome |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102319350A (en) | External scald oil medicinal composition for treating burns and scalds | |
| CN101766773A (en) | Traditional Chinese medicine formula for treating heel pain | |
| CN101732588A (en) | Formula of Chinese medicament for treating bodily pain syndrome | |
| CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
| CN102188661B (en) | Traditional Chinese medicine for removing arthralgia and preparation method thereof | |
| CN101920003B (en) | Traditional Chinese medicine composite for reducing fat and losing weight and preparation method thereof | |
| CN106390077A (en) | Pharmaceutical composition for treating stomachache and diarrhea and preparation method and application thereof | |
| CN115645451A (en) | Tibetan bath composition, tibetan bath medicament, preparation method and use method | |
| CN101129697A (en) | Orally taken traditional Chinese medicine composition for treating atrophic arthritis | |
| CN104027742A (en) | Orally-taken traditional Chinese medicine composition for treating fibromyalgia syndrome | |
| CN101983650A (en) | Medicament for treating dermatitis aestivale | |
| CN101780193A (en) | Special-effect plaster for treating fractures and various non-healing wounds | |
| CN1264591A (en) | Medicine for treating psoriasis and preparing process thereof | |
| CN104887970A (en) | Acupuncture and moxibustion physiotherapy ointment for external use | |
| CN1194859A (en) | Medicine for treating colitis | |
| CN1177606C (en) | Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process | |
| CN103520283A (en) | Foot bath powder and preparation method thereof | |
| CN102188566B (en) | Medicinal liquor for treating ischialgia | |
| CN102205006A (en) | External medicament for treating osteomyelitis and preparation method thereof | |
| CN103893436B (en) | A kind of externally applied drug for treating rheumatism | |
| CN101732648B (en) | Medicament for treating nonunion | |
| CN1326548C (en) | Medicine for treating gonorrhoea | |
| CN101607007B (en) | Traditional Chinese medicine preparation for treating cerebral circulation insufficiency | |
| CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation | |
| CN101264193A (en) | Chinese medicine for treating breast bump and mammary hyperplasia and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |